News

MimiVax Announces New Investments to Support Clinical Development of SurVaxM in Glioblastoma  MimiVax, Inc., a biotechnology company focused on the development of SurVaxM, a survivin-targeted vaccine therapy for glioblastoma and other cancers, today announced new investments from the venture philanthropy arms of leading brain tumor patient organizations, VC, private and existing investors.  The investments from the Brain Tumor Investment Fund (BTIF), an affiliate of the National Brain Tumor Society (NBTS), […] January 9, 2024

Cordance Medical and EXACT Therapeutics Announce Strategic Partnership to Revolutionize Drug Delivery to the Brain Cordance Medical, a leading innovator in non-invasive opening of the blood-brain barrier (BBB), and EXACT Therapeutics, a clinical-stage Norwegian biopharmaceutical precision health company developing Acoustic Cluster Therapy (ACT®), today announced a strategic partnership aimed at combining their breakthrough technologies to revolutionize drug delivery in the treatment of brain diseases. Cordance Medical’s NeuroAccess™ platform is designed […] September 7, 2023

Kiyatec Announces Investment from Leading Brain Cancer Venture Philanthropy Funds Leader in functional precision oncology received funding support from investment arms of the National Brain Tumor Society and the Sontag Foundation KIYATEC, Inc., the leader in functional precision oncology technology, today announced a new investment from the venture philanthropy arms of two leading brain tumor patient organizations. The Brain Tumor Investment Fund, a affiliate of […] May 18, 2023

Brain Tumor Investment Fund Names Managing Director  National Brain Tumor Society’s venture philanthropy affiliate appoints industry veteran to lead fund designed to invest in and accelerate development of promising new technologies for patients with brain cancer. Today, the Brain Tumor Investment Fund, an affiliate of the National Brain Tumor Society (NBTS), announced that it has named John Higgins, a 30-year veteran of […] April 25, 2023

Science Publication First to Describe Modifi Bio’s Novel Approach to Fight Cancer Cells with DNA Modification Yale Spinout Modifi Bio announces seed funding NEW HAVEN, Conn., July 28, 2022 (GLOBE NEWSWIRE) — Modifi Biosciences announced today that the journal Science has published a critical study validating the company’s novel oncology platform based on new classes of molecules that exploit tumor-associated DNA repair defects through direct cancer cell DNA modification. The company closed a $6.4M seed […] August 1, 2022